Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 54.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,128 shares of the company’s stock after selling 21,295 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Bath & Body Works were worth $782,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of BBWI. Front Row Advisors LLC purchased a new position in Bath & Body Works during the third quarter worth about $25,000. Trust Co. of Vermont purchased a new stake in shares of Bath & Body Works during the 3rd quarter valued at approximately $27,000. Money Concepts Capital Corp raised its position in shares of Bath & Body Works by 1,180.4% during the 4th quarter. Money Concepts Capital Corp now owns 653 shares of the company’s stock valued at $28,000 after buying an additional 602 shares during the period. Bruce G. Allen Investments LLC purchased a new stake in shares of Bath & Body Works during the 4th quarter valued at approximately $44,000. Finally, Dark Forest Capital Management LP raised its position in shares of Bath & Body Works by 11,890.0% during the 1st quarter. Dark Forest Capital Management LP now owns 1,199 shares of the company’s stock valued at $44,000 after buying an additional 1,189 shares during the period. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Stock Down 2.0 %

NYSE:BBWI opened at $43.70 on Wednesday. The company has a fifty day simple moving average of $46.20 and a two-hundred day simple moving average of $39.96. The company has a market cap of $9.83 billion, a price-to-earnings ratio of 11.35, a price-to-earnings-growth ratio of 1.47 and a beta of 1.86. Bath & Body Works, Inc. has a 52 week low of $27.30 and a 52 week high of $50.34.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping the consensus estimate of $1.85 by $0.21. The business had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.86 earnings per share. On average, analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.83%. Bath & Body Works’s payout ratio is currently 20.78%.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. The Goldman Sachs Group lifted their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research report on Monday, March 4th. Evercore ISI lifted their price target on shares of Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a research report on Friday, March 1st. Telsey Advisory Group reaffirmed an “outperform” rating and set a $53.00 price target on shares of Bath & Body Works in a research report on Friday, April 5th. Robert W. Baird lifted their target price on shares of Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Finally, UBS Group lifted their target price on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a report on Monday, March 4th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $46.33.

Insider Buying and Selling

In related news, insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at $2,248,548.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.